Method for culturing human primary cells

A culturing method and primary cell technology are applied in the field of culturing human-derived primary cells to achieve the effects of reducing the amount of bacteria, improving the success rate and reversing bacterial contamination

Pending Publication Date: 2022-08-05
FIRST HOSPITAL OF SHANXI MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether to use combination th...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for culturing human primary cells
  • Method for culturing human primary cells
  • Method for culturing human primary cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 Isolation and culture of primary cells

[0041] A fresh human colorectal tumor specimen of about 0.5 × 0.5 cm in size was taken from surgical resection, and the adipose tissue was trimmed, immediately placed in PBS solution with penicillin and streptomycin, aseptically sealed, and sent to the laboratory at low temperature. Irradiate the ultra-clean bench with UV light for 30 minutes, turn on the fan for self-cleaning for 3 minutes, rinse the tumor tissue with sterile PBS three times in the sterile ultra-clean bench, discard the supernatant, add sterile penicillin, streptomycin and a small amount of sterile cell culture The solution was placed in a petri dish, and the specimen was cut into tissues of approximately 0.03-0.08 mm in size with sterile ophthalmic scissors. Using human tumor tissue separation reagent (purchased from Miltenyi Bioted), digest and disintegrate and make it loose by pipetting, suck the tissue fragments into a 6 cm petri dish, add 4 mL of ...

Embodiment 2

[0042] Example 2 Bacterial identification by Vitek MS mass spectrometry

[0043] Dip the culture solution with a disposable inoculating loop and inoculate it on the blood agar plate, the chocolate agar plate and the MacConkey plate, respectively, and place it on the blood agar plate, the chocolate agar plate and the MacConkey plate. %CO 2 After incubation in the incubator for 18-24 hours, the bacterial colonies were observed for growth and purified.

[0044] Pick a single purified colony, apply 0.95 μl of Vitek MS-CHCA matrix to the target plate, and then dry at room temperature; if the bacteria are suspected of having cell walls, add 0.45 μl of 25% formic acid first, and then add 0.95 μl of Vitek MS-CHCA matrix after drying at room temperature. Input the sample information into the mass spectrometer workstation, put the target plate into the Vitek MS instrument for MS detection, obtain the MALDI-TOF peak map, and match the bacterial species to Achromobacter xyloseoxidizing a...

Embodiment 3

[0045] Example 3 Drug susceptibility detection by Vitek 2compact instrument

[0046] Remove the 0.45% NaCl bottle from the refrigerator and return to room temperature. Take a disposable transparent plastic test tube, add 3 ml of sterile 0.45% NaCl to each tube, adjust the pH to 7.0, pick colonies and dissolve them into the saline in the test tube. Test with a turbidimeter, and adjust the turbidity of the bacteria test tube within the range of 0.5-0.63McF.

[0047] Achromobacter xyloseoxidizing bacteria and Pseudomonas aeruginosa were Gram-negative bacteria, and Gram-negative bacteria drug susceptibility card N335 was selected for drug susceptibility testing of the two strains. Before use, take the drug susceptibility card out of the refrigerator, return to room temperature, place the bacterial suspension test tube and the drug susceptibility card in sequence on the card carrier, and insert the catheter of the drug susceptibility card into the bacterial suspension. Enter the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a human primary cell culture method, and relates to the technical field of cell culture. In the human primary cell culture process, the supernatant of the suspected polluted cell culture solution is subjected to bacterial identification and drug sensitivity detection, and the types and concentrations of antibiotics which have no influence on the cell growth are selected according to the drug sensitivity test result after the cell culture is polluted, so that the bacterial pollution can be reversed in the early stage; the success rate of primary cell culture is greatly improved, and the method plays an important role in timely rescue of precious adherent cell pollution in cell culture.

Description

technical field [0001] The invention relates to the technical field of cell culture, in particular to a method for culturing human-derived primary cells. Background technique [0002] Primary culture, also called primary culture, is the first culture in vitro after tissue cells are obtained from a donor. Because the primary cells have just been separated from the tissue, their biological characteristics have not changed much, and they still retain their original genetic characteristics. The gene retention is more than 90%, which is also the closest to and reflects the in vivo growth characteristics. Therefore, it is used in antitumor drug treatment. It is more valuable in experimental studies such as sensitivity test, cell differentiation, and gene expression. [0003] Bacterial contamination is unavoidable in cell culture work. In previous studies, PCR technology is often used to detect bacterial contamination in cultured cells. However, the DNA extraction and PCR detectio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/09C12N5/071
CPCC12N5/0693C12N5/0679
Inventor 宋丽薇武志芳任宁兰丽珍李思进薛绪亭谭雯月
Owner FIRST HOSPITAL OF SHANXI MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products